Imperial College-London: Weight-loss Drug Liraglutide Slowed Alzheimer's Decline
December 06, 2025
December 06, 2025
LONDON, England, Dec. 6 (TNSjou) -- Imperial College-London issued the following news:
* * *
Weight-loss drug liraglutide slowed Alzheimer's decline
A drug prescribed for diabetes and weight loss has been shown to reduce brain shrinkage in Alzheimer's patients by almost 50%.
By Samantha Rey
The drug, called liraglutide, is one of the glucagon-like peptide receptor (GLP-1) agonists which also includes semaglutide - known a . . .
* * *
Weight-loss drug liraglutide slowed Alzheimer's decline
A drug prescribed for diabetes and weight loss has been shown to reduce brain shrinkage in Alzheimer's patients by almost 50%.
By Samantha Rey
The drug, called liraglutide, is one of the glucagon-like peptide receptor (GLP-1) agonists which also includes semaglutide - known a . . .